Recently, it has been shown that GIST show a gene expression profile suggestive of possible response to immune checkpoint inhibitors (13) and, in particular, that PDGFRA mutant GIST displays a more prominent immune cell pathway when compared to KIT mutant GIST (14). This evidence concerns the gene PDGFRA and gastrointestinal stromal tumor.